>
Leaked phone call confirms the WNBA is in deep sh*t…
Why Not Just Admit It? The Welfare-Warfare State Has Failed.
700 OpenAI Bots Took Part in Massive Hacking Attack
ICE arrests explode as Trump hands cops sweeping new powers...
Singapore is experimenting with biological computing using living human neurons...
It's Happening - Europe is Building an Impossible Fusion Reactor
Portable 1MW Kaleidos Microreactor Secures Critical Nuclear Fuel Deal Through 2030s
This New All-In-One Range Extender Is Ready To Go Into Any Electric Truck
Aptera Reveals The Secret To Building Its Solar EV: China
High-voltage sodium home battery emerges as affordable rooftop solar solution
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance...
China has released Origin Pilot, claimed to be the world's first open-source operating system...
ShieldAI XBAT Drone Fighters Can Give A Fighter Drone Wing to Every US Destroyer
Brain organoids, kept alive more than five years, matured like human brains

Scientists at University College London (UCL) have demonstrated in rodents a new type of "micromagnet" that can work as a miniaturized mechanical switch to turn on touch-sensitive cells, offering a new method for controlling specific regions of the brain.
There are parallels between this breakthrough and another exciting branch of research focused on careful control of cells in the body, known as optogenetics. This technique involves inserting genes into otherwise regular calls to make them sensitive to light, allowing them to be stimulated for the purposes of treating paralysis, relieving pain and restoring vision.
Although there have been success stories, such as a case when optogenetics was used for partial vision restoration in a human for the first time last year, adapting the technology for clinical use has proven difficult due to the need for genetic modification of the cells. The UCL team has come up with another way of controlling brain activity that doesn't involve such measures.
"Our new technology uses magnetic particles and magnets to remotely and precisely control brain cell activity and, importantly, does this without introducing any device or foreign gene into the brain," said lead researcher Dr Yichao Yu.
The team's magnet-centric approach involves targeting brain cells called astrocytes, which live between the brain's blood vessels and nerve cells and supply neurons with metabolic and structural support, while also regulating activity of neuronal circuits. Conveniently for the scientists, they also happen to be touch-sensitive.
"Because astrocytes are sensitive to touch, decorating them with magnetic particles means you can give the cells a tiny prod from outside the body using a magnet, and as such, control their function," said senior author, Professor Mark Lythgoe. "This ability to remotely control astrocytes provides a new tool for understanding their function and may have the potential to treat brain and mood disorders, including depression."